4.7 Article

Stem Cell Technology for Neurodegenerative Diseases

期刊

ANNALS OF NEUROLOGY
卷 70, 期 3, 页码 353-361

出版社

WILEY
DOI: 10.1002/ana.22487

关键词

-

资金

  1. A. Alfred Taubman Medical Research Institute
  2. Program for Neurology Research and Discovery
  3. NINDS [T32 NS007222-28]
  4. Juvenile Diabetes Research Foundation

向作者/读者索取更多资源

Over the past 20 years, stem cell technologies have become an increasingly attractive option to investigate and treat neurodegenerative diseases. In the current review, we discuss the process of extending basic stem cell research into translational therapies for patients suffering from neurodegenerative diseases. We begin with a discussion of the burden of these diseases on society, emphasizing the need for increased attention toward advancing stem cell therapies. We then explain the various types of stem cells utilized in neurodegenerative disease research, and outline important issues to consider in the transition of stem cell therapy from bench to bedside. Finally, we detail the current progress regarding the applications of stem cell therapies to specific neurodegenerative diseases, focusing on Parkinson disease, Huntington disease, Alzheimer disease, amyotrophic lateral sclerosis, and spinal muscular atrophy. With a greater understanding of the capacity of stem cell technologies, there is growing public hope that stem cell therapies will continue to progress into realistic and efficacious treatments for neurodegenerative diseases. ANN NEUROL 2011;70:353-361

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据